Osborne Partners Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $248K | Sell |
685
-11,425
| -94% | -$3.91M | 0.01% | 187 |
|
|
2026
Q1 | $4.26M | Hold |
12,110
| – | – | 0.23% | 104 |
|
|
2025
Q4 | $3.96M | Hold |
12,110
| – | – | 0.2% | 107 |
|
|
2025
Q3 | $3.42M | Hold |
12,110
| – | – | 0.17% | 112 |
|
|
2025
Q2 | $3.38M | Sell |
12,110
-365
| -3% | -$103K | 0.18% | 114 |
|
|
2025
Q1 | $3.89M | Hold |
12,475
| – | – | 0.22% | 107 |
|
|
2024
Q4 | $3.25M | Buy |
12,475
+50
| +0.4% | +$14.8K | 0.19% | 110 |
|
|
2024
Q3 | $4M | Buy |
12,425
+60
| +0.5% | +$19.6K | 0.23% | 106 |
|
|
2024
Q2 | $3.86M | Hold |
12,365
| – | – | 0.23% | 107 |
|
|
2024
Q1 | $3.52M | Hold |
12,365
| – | – | 0.22% | 108 |
|
|
2023
Q4 | $3.56M | Hold |
12,365
| – | – | 0.23% | 106 |
|
|
2023
Q3 | $3.32M | Sell |
12,365
-200
| -2% | -$49.9K | 0.25% | 101 |
|
|
2023
Q2 | $2.79M | Hold |
12,565
| – | – | 0.2% | 107 |
|
|
2023
Q1 | $3.04M | Hold |
12,565
| – | – | 0.22% | 106 |
|
|
2022
Q4 | $3.3M | Hold |
12,565
| – | – | 0.26% | 99 |
|
|
2022
Q3 | $2.83M | Hold |
12,565
| – | – | 0.24% | 106 |
|
|
2022
Q2 | $3.06M | Buy |
+12,565
| New | +$3.08M | 0.23% | 103 |
|
|
2021
Q1 | – | Sell |
-12,425
| Closed | -$2.86M | – | 194 |
|
|
2020
Q4 | $2.86M | Buy |
+12,425
| New | +$2.86M | 0.35% | 80 |
|
|
2019
Q4 | – | Sell |
-4,125
| Closed | -$798K | – | 155 |
|
|
2019
Q3 | $798K | Buy |
4,125
+125
| +3% | +$24K | 0.16% | 92 |
|
|
2019
Q2 | $737K | Sell |
4,000
-200
| -5% | -$35.8K | 0.14% | 98 |
|
|
2019
Q1 | $798K | Sell |
4,200
-12,679
| -75% | -$2.42M | 0.16% | 90 |
|
|
2018
Q4 | $3.29M | Hold |
16,879
| – | – | 0.49% | 67 |
|
|
2018
Q3 | $3.5M | Sell |
16,879
-106
| -0.6% | -$20.9K | 0.45% | 76 |
|
|
2018
Q2 | $3.13M | Buy |
16,985
+56
| +0.3% | +$9.91K | 0.43% | 79 |
|
|
2018
Q1 | $2.89M | Sell |
16,929
-94
| -0.6% | -$17.3K | 0.4% | 78 |
|
|
2017
Q4 | $2.96M | Hold |
17,023
| – | – | 0.39% | 78 |
|
|
2017
Q3 | $3.17M | Hold |
17,023
| – | – | 0.43% | 78 |
|
|
2017
Q2 | $2.93M | Buy |
17,023
+91
| +0.5% | +$14.8K | 0.42% | 77 |
|
|
2017
Q1 | $2.78M | Buy |
16,932
+109
| +0.6% | +$18.1K | 0.4% | 81 |
|
|
2016
Q4 | $2.46M | Hold |
16,823
| – | – | 0.36% | 83 |
|
|
2016
Q3 | $2.81M | Sell |
16,823
-225
| -1% | -$38K | 0.42% | 74 |
|
|
2016
Q2 | $2.59M | Hold |
17,048
| – | – | 0.39% | 75 |
|
|
2016
Q1 | $2.56M | Hold |
17,048
| – | – | 0.38% | 77 |
|
|
2015
Q4 | $2.77M | Sell |
17,048
-150
| -0.9% | -$23.6K | 0.4% | 76 |
|
|
2015
Q3 | $2.38M | Hold |
17,198
| – | – | 0.35% | 77 |
|
|
2015
Q2 | $2.64M | Hold |
17,198
| – | – | 0.35% | 79 |
|
|
2015
Q1 | $2.75M | Hold |
17,198
| – | – | 0.36% | 77 |
|
|
2014
Q4 | $2.74M | Hold |
17,198
| – | – | 0.33% | 74 |
|
|
2014
Q3 | $2.42M | Sell |
17,198
-50
| -0.3% | -$6.53K | 0.31% | 76 |
|
|
2014
Q2 | $2.04M | Sell |
17,248
-600
| -3% | -$69.5K | 0.26% | 83 |
|
|
2014
Q1 | $2.2M | Sell |
17,848
-205
| -1% | -$24.9K | 0.29% | 81 |
|
|
2013
Q4 | $2.06M | Buy |
18,053
+600
| +3% | +$68.3K | 0.27% | 82 |
|
|
2013
Q3 | $1.95M | Sell |
17,453
-200
| -1% | -$21.7K | 0.27% | 84 |
|
|
2013
Q2 | $1.74M | Buy |
+17,653
| New | +$1.83M | 0.25% | 86 |
|
Other funds holding AMGN
Osborne Partners Capital Management's AMGN Position: Q2 2026 in Review
Osborne Partners Capital Management reduced its Amgen (AMGN) stake by 94% in Q2 2026, selling an estimated $3.91M and leaving 685 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #187.
Osborne Partners Capital Management first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.26M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Osborne Partners Capital Management held 685 shares of Amgen worth $248K as of Q2 2026.
- Osborne Partners Capital Management sold 11,425 Amgen shares in Q2 2026, an estimated $3.91M.
- Amgen made up 0.01% of Osborne Partners Capital Management's portfolio in Q2 2026, its #187 holding.
- Osborne Partners Capital Management first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
- Osborne Partners Capital Management's Amgen position peaked at $4.26M in Q1 2026.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.